Results 121 to 130 of about 1,192,898 (301)
This study presents a comprehensive analysis of a Power-to-Methanol (PtM) process, which converts CO2 and H2 derived from electrolysis of water into methanol (MeOH) using renewable energy sources.
Ali Pakdel, Reza Eslamloueyan
doaj +1 more source
Haber-Bosch – en Power-to-X-teknologi
Udviklingen af Haber-Bosch-processen til fremstilling af ammoniak er blevet kaldt den vigtigste opfindelse i det 20. århundrede. På trods af at processen er over 100 år gammel, er den stadig yderst relevant i dag. Men hvorfor er den det, og kan vi stadig blive endnu klogere på denne velkendte teknologi?
Hansen, Simon Ingeman +2 more
openaire +1 more source
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye +11 more
wiley +1 more source
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang +10 more
wiley +1 more source
Der Energiesoli: Alternative Finanzierungsmodelle für die Energiewende
Der Ausbau der Erneuerbaren Energien zur Stromerzeugung wird in Deutschland durch die EEG-Umlage gefördert. Die Umlage belastet alle Stromverbraucher, unab-hängig davon, ob sie erneuerbar oder fossil erzeugten Strom nutzen.
Schaefer, Thilo
core
CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang +6 more
wiley +1 more source
Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi +19 more
wiley +1 more source
Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann +17 more
wiley +1 more source
Power-to-X-teknologian hyödyntäminen Laanilan teollisuusalueella
Tiivistelmä. Tämän työn tavoitteina oli muodostaa selkeä yleiskuva Oulussa sijaitsevan Laanilan teollisuusalueen yritysten aine- ja energiavirroista, tunnistaa Power-to-X-teknologian kannalta oleelliset ainevirrat, selvittää kirjallisuudesta Laanilan teollisuuteen sopivia Power-to-X-teknologioita ja tarkastella aine- ja energiatasetasolla ...
openaire +1 more source
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source

